These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3123207)

  • 1. Effect of repeated subcutaneous administration of growth hormone releasing factor (GRF 1-44) on hypophysis in GH-deficient children.
    Szarras-Czapnik M; Rymkiewicz-Kluczyńska B; Romer T
    Endokrynol Pol; 1987; 38(1):15-9. PubMed ID: 3123207
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of growth hormone responses to classical stimulation tests and to intravenous administration of growth hormone releasing factor (GRF 1-44) in children with growth hormone deficiency.
    Rymkiewicz-Kluczyńska B; Szarras-Czapnik M; Romer T
    Endokrynol Pol; 1987; 38(1):9-13. PubMed ID: 3123208
    [No Abstract]   [Full Text] [Related]  

  • 3. [Somatocrinin and children in 1984. Application to the etiological diagnosis of somatotropin deficiencies].
    Chatelain P; Bertrand J; David M; Sassolas G; Catbeh N; Morel Y; Ruitton A; Ferry S; Gilly R; Philip T
    Arch Fr Pediatr; 1985 Mar; 42(3):205-9. PubMed ID: 3923994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous treatment with growth hormone-releasing hormone for short stature.
    Hernández M; Fragoso J; Barrio R; Argente J; Arilla E
    Horm Res; 1988; 30(6):252-7. PubMed ID: 2907992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency.
    Lustig RH; Schriock EA; Kaplan SL; Grumbach MM
    Pediatrics; 1985 Aug; 76(2):274-9. PubMed ID: 3927254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
    Takano K; Hizuka N; Shizume K; Honda N; Ling NC
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma growth hormone (GH) response to intravenous GH-releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation.
    Arsenijevic Y; Rivest RW; Eshkol A; Sizonenko PC; Aubert ML
    Endocrinology; 1987 Oct; 121(4):1487-96. PubMed ID: 2888646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone-releasing hormone in the diagnosis and treatment of growth hormone deficient children.
    Ross RJ; Grossman A; Besser GM; Savage MO
    Acta Endocrinol Suppl (Copenh); 1986; 279():123-9. PubMed ID: 3096037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Somatocrinin induces growth hormone release in a case of growth hormone deficiency of hypothalamic origin in a child].
    Sassolas G; Rousset H; Cohen R; Chatelain P; Claustrat B; Laporte S; Laferrère B; El Charfi A; Ferry S
    C R Seances Acad Sci III; 1983; 296(11):527-30. PubMed ID: 6409361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute intravenous growth hormone-releasing factor on plasma prolactin in short children and patients with growth hormone deficiency.
    Chatelain PG; Sassolas G; Catbeh N; Bio-Laporte S; Ferry S; Claustrat B; David M; François R
    Horm Res; 1985; 22(1-2):46-51. PubMed ID: 3928476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective response of plasma growth hormone to growth hormone releasing factor in growth hormone deficient children.
    Ko FY; Chen WP; Lin CY
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(4):243-50. PubMed ID: 1296432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of intranasal insufflation of growth hormone releasing factor analogue GRF 1-29 NH2 on growth hormone secretion in children with short stature.
    Borkenstein M
    Acta Endocrinol Suppl (Copenh); 1986; 279():135-8. PubMed ID: 2877535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
    Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone-releasing hormone reverses secondary somatotroph unresponsiveness.
    Romer TE; Rymkiewicz-Kluczynska B; Olivier M; Sagnard L; Szarras-Czapnik M
    J Clin Endocrinol Metab; 1991 Feb; 72(2):503-6. PubMed ID: 1991817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH)-releasing factor (GRF) pretreatment enhances the GRF-induced GH secretion in rats with the pituitary autotransplanted to the kidney capsule.
    Jansson JO; Carlsson L; Isaksson OG
    Endocrinology; 1985 Jan; 116(1):95-8. PubMed ID: 3917256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma growth hormone (GH) responses to growth hormone releasing factor (hp GRF 1-44) in familial GH deficiency.
    Kibirige MS; Price DA; Shalet SM; Bailie GR
    Acta Paediatr Scand; 1987 Jan; 76(1):103-6. PubMed ID: 3105240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
    Rogol AD; Blizzard RM; Johanson AJ; Furlanetto RW; Evans WS; Rivier J; Vale WW; Thorner MO
    J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist.
    Lumpkin MD; McDonald JK
    Endocrinology; 1989 Mar; 124(3):1522-31. PubMed ID: 2537185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of growth hormone response to growth hormone-releasing factor 1-44 according to the combined study of sleep secretion with the responses to pharmacologic stimuli.
    Garnier P; Liapi C; Raynaud F; Evain-Brion D
    Horm Res; 1987; 28(1):13-9. PubMed ID: 3129352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed release formulation of the somatostatin analog RC-160 inhibits the growth hormone (GH) response to GH-releasing factor-(1-29)NH2 and decreases elevated prolactin levels in rats.
    Bokser L; Schally AV
    Endocrinology; 1988 Oct; 123(4):1735-9. PubMed ID: 2901338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.